COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01733394
Recruitment Status : Completed
First Posted : November 27, 2012
Last Update Posted : July 19, 2017
American Epilepsy Society
Epilepsy Foundation
Information provided by (Responsible Party):
Michael Privitera, University of Cincinnati

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 26, 2016
Actual Study Completion Date : September 26, 2016